Neurocrine Biosciences Inc SEC filings NBIX

Neurocrine Biosciences Inc has 1,001 filings in SEC EDGAR's recent list, going back to Feb 8, 2018. Its latest annual report, Form ARS, was filed on Apr 15, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 2, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 2, 2026 (results of operations). The company's fiscal year ends on December 31.

Neurocrine Biosciences Inc SEC filings
Form Description Filed Period
4 Insider transaction Nov 5, 2026 Nov 4, 2026
4 Insider transaction Nov 3, 2026 Oct 30, 2026
4 Insider transaction Nov 3, 2026 Nov 1, 2026
144 Notice of proposed sale Nov 2, 2026 —
10-Q Quarterly report Nov 2, 2026 Sep 30, 2026
8-K Current report
Results of operations
Nov 2, 2026 Nov 2, 2026
144 Notice of proposed sale Oct 30, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Oct 30, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Oct 15, 2026 —
3 Initial insider ownership Oct 7, 2026 Sep 28, 2026
8-K Current report
Officer or director change
Sep 28, 2026 Sep 25, 2026
4 Insider transaction Sep 15, 2026 Sep 11, 2026
4 Insider transaction Sep 15, 2026 Sep 11, 2026
4 Insider transaction Sep 15, 2026 Sep 11, 2026
4 Insider transaction Sep 15, 2026 Sep 11, 2026
4 Insider transaction Sep 15, 2026 Sep 11, 2026
4 Insider transaction Sep 15, 2026 Sep 11, 2026
4 Insider transaction Sep 15, 2026 Sep 11, 2026
4 Insider transaction Sep 15, 2026 Sep 11, 2026
4 Insider transaction Sep 15, 2026 Sep 11, 2026
4 Insider transaction Sep 15, 2026 Sep 11, 2026
144 Notice of proposed sale Sep 14, 2026 —
144 Notice of proposed sale Sep 14, 2026 —
4 Insider transaction Sep 10, 2026 Sep 9, 2026
144 Notice of proposed sale Sep 9, 2026 —
4 Insider transaction Sep 3, 2026 Sep 2, 2026
4 Insider transaction Aug 5, 2026 Aug 4, 2026
S-8 Employee stock plan registration Jul 31, 2026 —
8-K/A Amended current report Jul 31, 2026 May 14, 2026
10-Q Quarterly report Jul 31, 2026 Jun 30, 2026
4 Insider transaction Jul 30, 2026 Jul 28, 2026
8-K Current report
Results of operations
Jul 30, 2026 Jul 30, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Jul 27, 2026 —
4 Insider transaction Jul 13, 2026 Jul 10, 2026
4 Insider transaction Jul 13, 2026 Jul 9, 2026
144 Notice of proposed sale Jul 10, 2026 —
4 Insider transaction Jul 9, 2026 Jul 7, 2026
144 Notice of proposed sale Jul 9, 2026 —
144 Notice of proposed sale Jul 7, 2026 —
4 Insider transaction Jun 30, 2026 Jun 26, 2026
144 Notice of proposed sale Jun 29, 2026 —
144 Notice of proposed sale Jun 26, 2026 —
4 Insider transaction Jun 9, 2026 Jun 5, 2026
4 Insider transaction Jun 9, 2026 Jun 5, 2026
4 Insider transaction Jun 8, 2026 Jun 4, 2026
144 Notice of proposed sale Jun 5, 2026 —
4 Insider transaction Jun 4, 2026 Jun 2, 2026
4 Insider transaction Jun 4, 2026 Jun 2, 2026
4 Insider transaction Jun 2, 2026 Jun 1, 2026
4 Insider transaction Jun 2, 2026 May 29, 2026
144 Notice of proposed sale Jun 2, 2026 —
144 Notice of proposed sale Jun 1, 2026 —
4 Insider transaction May 29, 2026 May 27, 2026
4 Insider transaction May 29, 2026 May 27, 2026
4 Insider transaction May 29, 2026 May 27, 2026
4 Insider transaction May 29, 2026 May 27, 2026
4 Insider transaction May 29, 2026 May 27, 2026
4 Insider transaction May 29, 2026 May 27, 2026
4 Insider transaction May 29, 2026 May 27, 2026
4 Insider transaction May 29, 2026 May 27, 2026
4 Insider transaction May 29, 2026 May 27, 2026
4 Insider transaction May 29, 2026 May 27, 2026
4 Insider transaction May 29, 2026 May 27, 2026
144 Notice of proposed sale May 29, 2026 —
4 Insider transaction May 28, 2026 May 26, 2026
8-K Current report
Officer or director change, Shareholder vote results
May 28, 2026 May 27, 2026
144 Notice of proposed sale May 27, 2026 —
144 Notice of proposed sale May 26, 2026 —
4 Insider transaction May 21, 2026 May 21, 2026
4 Insider transaction May 21, 2026 May 21, 2026
4 Insider transaction May 21, 2026 May 21, 2026
4 Insider transaction May 21, 2026 May 21, 2026
4 Insider transaction May 21, 2026 May 21, 2026
4 Insider transaction May 21, 2026 May 21, 2026
4 Insider transaction May 21, 2026 May 21, 2026
4 Insider transaction May 21, 2026 May 21, 2026
4 Insider transaction May 21, 2026 May 21, 2026
4 Insider transaction May 21, 2026 May 19, 2026
144 Notice of proposed sale May 19, 2026 —
4 Insider transaction May 18, 2026 May 15, 2026
8-K Current report
Material agreement, Acquisition or sale of assets, New debt, Regulation FD disclosure
May 18, 2026 May 14, 2026
SC TO-T/A Filing May 18, 2026 —
144 Notice of proposed sale May 15, 2026 —
4 Insider transaction May 14, 2026 May 12, 2026
144 Notice of proposed sale May 12, 2026 —
10-Q Quarterly report May 5, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 5, 2026 May 5, 2026
SCHEDULE 13G Ownership over 5% (passive) Apr 30, 2026 —
SC TO-T/A Filing Apr 29, 2026 —
SC TO-T/A Filing Apr 28, 2026 —
SC TO-T Filing Apr 20, 2026 —
ARS Annual report to shareholders Apr 15, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 15, 2026 —
DEF 14A Proxy statement Apr 15, 2026 Apr 15, 2026
SC TO-C Filing Apr 7, 2026 —
SC TO-C Filing Apr 6, 2026 —
SC TO-C Filing Apr 6, 2026 —
8-K Current report
Material agreement
Apr 6, 2026 Apr 5, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 27, 2026 —
3 Initial insider ownership Mar 17, 2026 Mar 15, 2026
4 Insider transaction Mar 5, 2026 Mar 4, 2026
4 Insider transaction Feb 23, 2026 Feb 20, 2026
4 Insider transaction Feb 17, 2026 Feb 12, 2026
4 Insider transaction Feb 17, 2026 Feb 12, 2026
4 Insider transaction Feb 17, 2026 Feb 12, 2026
4 Insider transaction Feb 17, 2026 Feb 12, 2026
4 Insider transaction Feb 17, 2026 Feb 12, 2026
4 Insider transaction Feb 17, 2026 Feb 12, 2026
4 Insider transaction Feb 17, 2026 Feb 12, 2026
4 Insider transaction Feb 17, 2026 Feb 12, 2026
4 Insider transaction Feb 17, 2026 Feb 13, 2026
4 Insider transaction Feb 17, 2026 Feb 13, 2026
10-K Annual report Feb 11, 2026 Dec 31, 2025
8-K Current report
Results of operations
Feb 11, 2026 Feb 11, 2026
4 Insider transaction Feb 3, 2026 Jan 31, 2026
4 Insider transaction Feb 3, 2026 Jan 31, 2026
4 Insider transaction Feb 3, 2026 Jan 31, 2026
4 Insider transaction Feb 3, 2026 Jan 31, 2026
4 Insider transaction Feb 3, 2026 Jan 31, 2026
4 Insider transaction Feb 3, 2026 Jan 31, 2026
4 Insider transaction Feb 3, 2026 Jan 31, 2026
4 Insider transaction Feb 3, 2026 Jan 31, 2026
4 Insider transaction Feb 3, 2026 Jan 31, 2026
SCHEDULE 13G Ownership over 5% (passive) Jan 21, 2026 —
4 Insider transaction Jan 20, 2026 Jan 16, 2026
4/A Form 4/a Jan 16, 2026 Nov 28, 2025
144 Notice of proposed sale Jan 16, 2026 —
4 Insider transaction Jan 12, 2026 Jan 8, 2026
4 Insider transaction Dec 17, 2025 Dec 15, 2025
144 Notice of proposed sale Dec 15, 2025 —
4 Insider transaction Dec 10, 2025 Dec 8, 2025
144 Notice of proposed sale Dec 8, 2025 —
4 Insider transaction Dec 4, 2025 Dec 3, 2025
144 Notice of proposed sale Dec 3, 2025 —
4 Insider transaction Dec 2, 2025 Nov 28, 2025
4 Insider transaction Dec 2, 2025 Nov 29, 2025
144 Notice of proposed sale Nov 28, 2025 —
4 Insider transaction Nov 26, 2025 Nov 25, 2025
144 Notice of proposed sale Nov 25, 2025 —
8-K Current report
Officer or director change
Nov 24, 2025 Nov 21, 2025
4 Insider transaction Nov 6, 2025 Nov 5, 2025
144 Notice of proposed sale Nov 5, 2025 —
144 Notice of proposed sale Nov 5, 2025 —
4 Insider transaction Nov 4, 2025 Nov 1, 2025
10-Q Quarterly report Oct 28, 2025 Sep 30, 2025
8-K Current report
Results of operations
Oct 28, 2025 Oct 28, 2025
4 Insider transaction Sep 4, 2025 Sep 3, 2025
4 Insider transaction Sep 3, 2025 Sep 2, 2025
4 Insider transaction Aug 11, 2025 Aug 7, 2025
4 Insider transaction Aug 7, 2025 Aug 5, 2025
144 Notice of proposed sale Aug 7, 2025 —
10-Q Quarterly report Jul 30, 2025 Jun 30, 2025
8-K Current report
Results of operations
Jul 30, 2025 Jul 30, 2025
4 Insider transaction Jul 11, 2025 Jul 10, 2025
4 Insider transaction Jul 11, 2025 Jul 9, 2025
144 Notice of proposed sale Jul 10, 2025 —
4 Insider transaction Jul 7, 2025 Jul 2, 2025
144 Notice of proposed sale Jul 2, 2025 —
4 Insider transaction Jun 4, 2025 Jun 2, 2025
3 Initial insider ownership Jun 4, 2025 Jun 2, 2025
8-K Current report
Officer or director change
May 30, 2025 May 30, 2025
4 Insider transaction May 29, 2025 May 27, 2025
144 Notice of proposed sale May 27, 2025 —
4 Insider transaction May 22, 2025 May 21, 2025
4 Insider transaction May 22, 2025 May 21, 2025
4 Insider transaction May 22, 2025 May 21, 2025
4 Insider transaction May 22, 2025 May 21, 2025
4 Insider transaction May 22, 2025 May 21, 2025
4 Insider transaction May 22, 2025 May 21, 2025
4 Insider transaction May 22, 2025 May 21, 2025
4 Insider transaction May 22, 2025 May 21, 2025
4 Insider transaction May 22, 2025 May 21, 2025
4 Insider transaction May 22, 2025 May 21, 2025
8-K Current report
Officer or director change, Shareholder vote results
May 22, 2025 May 21, 2025
S-8 POS Filing May 21, 2025 —
S-8 POS Filing May 21, 2025 —
S-8 POS Filing May 21, 2025 —
S-8 POS Filing May 21, 2025 —
S-8 POS Filing May 21, 2025 —
S-8 POS Filing May 21, 2025 —
S-8 POS Filing May 21, 2025 —
S-8 POS Filing May 21, 2025 —
S-8 POS Filing May 21, 2025 —
S-8 POS Filing May 21, 2025 —
S-8 POS Filing May 21, 2025 —
S-8 POS Filing May 21, 2025 —
S-8 Employee stock plan registration May 21, 2025 —
4 Insider transaction May 20, 2025 May 16, 2025
SCHEDULE 13G Ownership over 5% (passive) May 14, 2025 —
4 Insider transaction May 7, 2025 May 5, 2025
144 Notice of proposed sale May 5, 2025 —
10-Q Quarterly report May 5, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 5, 2025 May 5, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Apr 28, 2025 —
ARS Annual report to shareholders Apr 9, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 9, 2025 —
DEF 14A Proxy statement Apr 9, 2025 Apr 9, 2025
8-K Current report
Officer or director change, Regulation FD disclosure
Apr 4, 2025 Apr 2, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 6, 2025 —
4 Insider transaction Feb 14, 2025 Feb 12, 2025

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
NBIX (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
San Diego, CA
SEC filer status
Large accelerated filer
SEC CIK
914475

Other Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.